Minli Xie, Ph.D.
About Minli Xie, Ph.D.
Minli Xie, Ph.D., is a seasoned pharmaceutical executive with extensive experience in pharmaceutical chemistry and operations.
Minli Xie Senior Vice President of Pharmaceutical Development and Operations
Minli Xie, Ph.D., currently holds the position of Senior Vice President of Pharmaceutical Development and Operations. In this role, she is responsible for overseeing the development and operational strategies for pharmaceutical projects. Her leadership and expertise contribute significantly to the advancement of pharmaceutical initiatives within the company.
Minli Xie Education and Expertise in Pharmaceutical Chemistry
Minli Xie holds a Ph.D. in pharmaceutical chemistry from the University of Kansas. Her advanced education provides a strong foundation for her extensive career in pharmaceutical development and operations. The specialized knowledge she gained during her doctoral studies has been instrumental in her various leadership roles within the industry.
Minli Xie Background and Industry Experience
Minli Xie's career in the pharmaceutical industry spans multiple high-profile companies. She was one of the first 20 employees at Myovant Sciences, where she served as the Vice President of Pharmaceutical Operations and Development. Prior to this, she worked at Medivation as Head of Small Molecule Technical Operations. Xie also built and led the small molecule pharmaceutics team at Genentech, and she has held increasing levels of responsibility at Bristol Myers Squibb and DuPont Merck.
Minli Xie Role in Myovant Sciences
During her tenure at Myovant Sciences, Minli Xie was among the first 20 employees and served as Vice President of Pharmaceutical Operations and Development. In this capacity, she played a crucial role in shaping the company's pharmaceutical strategies and operational efficacy. Her efforts were pivotal in establishing and advancing the company's pharmaceutical development initiatives.
Minli Xie Contribution to Medivation
At Medivation, Minli Xie served as the Head of Small Molecule Technical Operations. Her work involved leading the technical operations for small molecule pharmaceuticals, ensuring their successful development and manufacturing. Her leadership in this role helped drive the company's progress in small molecule therapeutics.